Audiologic presentation of vestibular schwannomas in neurofibromatosis type 2

American Journal of Otology

Volumn 19, Issue 3, 1998, Pages 352-357

  Lalwani, Anil K ^a   Abaza, Mona M ^b   Makariou, Erini V ^c   Armstrong, Mark ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Hearing loss; Neurofibromatosis Type 2; Vestibular schwannomas

Indexed keywords

ADULT; ARTICLE; AUDIOLOGY; AUDITORY THRESHOLD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SPEECH PERCEPTION; TUMOR LOCALIZATION; TUMOR VOLUME; VESTIBULAR NERVE;

ADULT; AGED; AUDIOMETRY, PURE-TONE; EAR NEOPLASMS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING LOSS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURILEMMOMA; NEUROFIBROMATOSIS 2; REFLEX, VESTIBULO-OCULAR; RETROSPECTIVE STUDIES; SPEECH RECEPTION THRESHOLD TEST;

EID: 0031967193     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Eldridge R. Bilateral acoustic neurofibromatosis: genetic basis, natural history and counseling. In, Program and Abstracts of the National Institutes of Health Consensus Development Conference on Neurofibromatosis. 1993 Bethesda, MD.
2. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993;329:515-21.
3. Merel P, Hoang-Xuan K, Sanson M, et al. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer 1995;13:211-6.
4. MacCollon M, Ramesh V, Jacoby LB, et al. Mutational analysis of patients with Neurofibromatosis 2. Am J Hum Genet 1994;55:314-20.
5. Twist EC, Ruttledge MH, Rousseau M, et al. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 1994;3:147-51.
6. Selesnick SH, Jackler RK. Clinical manifestations and audiologic diagnosis of acoustic neuromas. Otolaryngol Clin North Am 1992; 25(3):521-51.
7. Wilson DF, Hodgson RS, Gustafson MF, et al. The sensitivity of auditory brainstem response testing in small acoustic neuromas. Laryngoscope 1992;102:961-4.
8. Telischi FF, Roth J, Stagner BB, et al. Patterns of evoked otoacoustic emissions associated with acoustic neuromas. Laryngoscope 1995;105:675-82.
9. Selesnick SH, Jackler RK. Atypical hearing loss in acoustic neuroma patients. Laryngoscope 1993;103:437-41.
10. Schlauch RS, Levine S, Li Y, et al. Evaluating hearing threshold differences between ears as a screen for acoustic neuromas. J Speech Hear Res 1995;38:1168-75.
11. Gordon ML, Cohen NL. Efficacy of auditory brainstem response as a screening test for small acoustic neuromas. Am J Otol 1995;16:136-9.
12. Burkey JM, Rizer FM, Schuring AG, et al. Acoustic reflexes, auditory brainstem response, and MRI in the evaluation of acoustic neuromas. Laryngoscope 1996;106:839-41.
13. Nadol JB, Diamond PF, Thornton AR. Correlation of hearing loss and radiologic dimensions of vestibular schwannomas (acoustic neuromas). Am J Otol 1996;17:312-6.
14. Abaza MM, Markariou E, Armstrong M, et al. Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2. Laryngoscope 1996;106:694-9.
15. Parry DM, MacCollin MM, Kaiser-Kupfer MI, et al. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 1996; 59:529-39.